Qidni TM Wearable Device

Division:South/North America

Field:Life Science and Health

Project Evaluation:12410 Financing Amount:Secret Cede Share:Secret

Submit Investment Intention

Project description

1 Description

Current Technology for patients with kidney failure: Dialysis  3 times a week, 4 hours each time  in center dialysis with a fridge size dialysis machine.

 Key Issues: Very Low Survival Rate (50% in 5 years) due to limited number   of dialysis sessions per week;Difficult access to treatment:   Patients live far away from clinics;Zero mobility of patients during  long hours of treatment  attached to the dialysis  machine.

Our solution: Qidni TM Wearable Device

*We want this to be the world’s smallest blood purification device. 

*It is a wearable blood purification system. 

*It replaces dialysis. 

*It provides more frequent therapy. It significantly improves the quality of life for patients with kidney failure by providing (i) mobility and (ii) easy access to blood purification. 

2 Innovation

QartridgeTM:  

•  A sorbent-like cartridge, based on our proprietary technology that  replaces large volume of “dialysate”.  

•  In the existing dialysis technology 120 L of purified water is mixed with salts to make a solution called“dialysate”weighing 120 kg for just one session of dialysis.  

•   We are on our way to create a QartridgeTM that weighs about 1 kg only.

3 Market & Risk

 Based on current reimbursement system in the US for a patient with private insurance. 

Note: we can probably get a much better reimbursement based on added value. 

** Assuming $500-$700 per session, 3 sessions/week, 52 weeks a year ($78,000-$102,200 per year )

Opportunity:  >$50 billion/year kidney dialysis market in the USA alone Solution: Portable/wearable blood purification systems (with minimum or no dialysate) that replace dialysis and (i) by enabling mobility and freedom, significantly improve the quality of life for 3 million dialysis patients; or (ii) saves lives by providing access to therapy for 20-30  million patients who currently do not have access to dialysis. 

4 Team & Operation

Founders:

*Morteza Ahmadi: PhD in Biomedical Engineering and Human Factors (University of Waterloo, Canada) KRESCENT Fellow (Kidney Foundation of Canada)

*Ellie Shahi :MMSc in Management Science (University of Waterloo, Canada)